{"id":"https://openalex.org/W26295571","doi":null,"title":"Biologic activities of natural and synthetic type I interferons.","display_name":"Biologic activities of natural and synthetic type I interferons.","publication_year":1997,"publication_date":"1997-06-01","ids":{"openalex":"https://openalex.org/W26295571","mag":"26295571","pmid":"https://pubmed.ncbi.nlm.nih.gov/9208874"},"language":"en","primary_location":{"id":"pmid:9208874","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9208874","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076720785","display_name":"Lawrence M. Pfeffer","orcid":"https://orcid.org/0000-0003-2809-1234","observed_orcids":["https://orcid.org/0000-0003-2809-1234"]},"institutions":[{"id":"https://openalex.org/I160606119","display_name":"University of Tennessee Health Science Center","ror":"https://ror.org/0011qv509","country_code":"US","type":"education","lineage":["https://openalex.org/I160606119"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"L M Pfeffer","raw_affiliation_strings":["Department of Pathology, University of Tennessee Health Science Center, Memphis 38163, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, University of Tennessee Health Science Center, Memphis 38163, USA","institution_ids":["https://openalex.org/I160606119"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5076720785"],"corresponding_institution_ids":["https://openalex.org/I160606119"],"apc_list":null,"apc_paid":null,"fwci":1.1257,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.76293871,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"24","issue":"3 Suppl 9","first_page":"S9","last_page":"63"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-i-interferon","display_name":"type I interferon","score":0.8309999704360962},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.8880000114440918},{"id":"https://openalex.org/keywords/recombinant-interferon","display_name":"recombinant interferon","score":0.7519999742507935},{"id":"https://openalex.org/keywords/interferon-receptor","display_name":"interferon receptor","score":0.6970000267028809},{"id":"https://openalex.org/keywords/receptor-binding","display_name":"receptor binding","score":0.7900000214576721},{"id":"https://openalex.org/keywords/antiviral-activity","display_name":"antiviral activity","score":0.9240000247955322},{"id":"https://openalex.org/keywords/vesicular-stomatitis-virus","display_name":"vesicular stomatitis virus","score":0.9549999833106995},{"id":"https://openalex.org/keywords/interferon-alpha-subtypes","display_name":"interferon-alpha subtypes","score":0.5709999799728394},{"id":"https://openalex.org/keywords/interferon-alpha-2b","display_name":"interferon alfa-2b","score":0.5450000166893005}],"concepts":[{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.7144858241081238},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.6665476560592651},{"id":"https://openalex.org/C2779057330","wikidata":"https://www.wikidata.org/wiki/Q162762","display_name":"Vesicular stomatitis virus","level":3,"score":0.6594316959381104},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6431522369384766},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.6345800161361694},{"id":"https://openalex.org/C2778278966","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Interferon type I","level":3,"score":0.5713943243026733},{"id":"https://openalex.org/C189014844","wikidata":"https://www.wikidata.org/wiki/Q189118","display_name":"Cell type","level":3,"score":0.5426737070083618},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.5325616598129272},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5082135200500488},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.49791812896728516},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.4911439120769501},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.4610222280025482},{"id":"https://openalex.org/C197462201","wikidata":"https://www.wikidata.org/wiki/Q2476074","display_name":"Cell surface receptor","level":3,"score":0.4324062466621399},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.4261510968208313},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34629708528518677},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3343357443809509},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3062005639076233},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.23658427596092224},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22931337356567383},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007370","descriptor_name":"Interferon Type I","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007370","descriptor_name":"Interferon Type I","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017471","descriptor_name":"Receptors, Interferon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9208874","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9208874","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},{"id":"mag:26295571","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9208874","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W1826995994"],"related_works":["https://openalex.org/W2071961343","https://openalex.org/W1967475015","https://openalex.org/W2002746052","https://openalex.org/W2462324476","https://openalex.org/W7095519755","https://openalex.org/W1818602010","https://openalex.org/W1532276762","https://openalex.org/W2147818004","https://openalex.org/W2043886637","https://openalex.org/W2045023213"],"abstract_inverted_index":{"Because":[0],"alpha-interferon":[1],"(IFN-alpha)":[2],"has":[3],"a":[4,54,64,97],"number":[5],"of":[6,12,18,23,27,66,88,128,156,189,197,219],"therapeutic":[7],"applications":[8],"in":[9,63,75,122,208,235,239,241],"the":[10,86,123,140,157,168,186,209,215,220,247],"treatment":[11],"various":[13,210,234,248],"human":[14],"cancers":[15],"and":[16,49,59,90,102,114,117,173],"diseases":[17],"viral":[19,187],"origin,":[20],"an":[21],"understanding":[22],"how":[24],"this":[25,82],"family":[26],"proteins":[28],"interacts":[29],"with":[30,85,139,167,202,214],"cells":[31,116,181],"to":[32,53,72,78,80,125,212,228],"induce":[33,60],"their":[34,76],"pleiotropic":[35],"biologic":[36,162],"activities":[37,178,188],"is":[38,226],"essential.":[39],"Available":[40],"data":[41],"suggest":[42],"that":[43,133,232],"recombinant":[44],"IFN-alphas":[45,69,136,158],"from":[46],"both":[47,152],"natural":[48],"synthetic":[50,100],"genes":[51],"bind":[52,79],"common":[55],"cell":[56,67,91,153],"surface":[57],"receptor":[58,109],"antiviral":[61,177],"activity":[62],"variety":[65],"lines.":[68,154],"were":[70,118,192],"found":[71],"differ":[73],"significantly":[74,193],"abilities":[77],"cells;":[81],"difference":[83],"varied":[84,166],"types":[87],"IFN-alpha":[89,142,216],"type":[92,221],"used.":[93,171],"Consensus":[94],"interferon":[95],"(IFN-con1),":[96],"nonnaturally":[98],"occurring":[99],"IFN,":[101],"IFN-alpha2b":[103,174],"competed":[104,146],"about":[105],"equally":[106],"well":[107],"for":[108,148],"binding":[110,149],"sites":[111,150],"on":[112,151,179],"Daudi":[113],"CaKi":[115,180],"followed":[119],"by":[120],"IFN-alpha8":[121],"ability":[124],"compete.":[126],"Results":[127],"affinity":[129],"cross-linking":[130],"experiments":[131],"indicated":[132],"all":[134],"three":[135],"interacted":[137],"similarly":[138],"multichain":[141],"receptor.":[143,224],"IFN-alpha7,":[144],"however,":[145,231],"poorly":[147],"Each":[155],"tested":[159],"displayed":[160,175],"discrete":[161],"differences,":[163],"which":[164],"also":[165],"assay":[169],"system":[170],"IFN-con1":[172],"similar":[176],"using":[182],"vesicular":[183],"stomatitis":[184],"virus;":[185],"these":[190,233],"IFNs":[191,211],"greater":[194],"than":[195],"those":[196],"IFN-alpha7":[198],"or":[199,244],"IFN-alpha8.":[200],"Studies":[201],"murine":[203],"transfectants":[204],"demonstrated":[205],"significant":[206],"differences":[207,240],"interact":[213],"receptor-1":[217],"chain":[218],"I":[222],"IFN":[223],"It":[225],"yet":[227],"be":[229],"established,":[230],"vitro":[236],"distinctions":[237],"result":[238],"clinical":[242],"benefit":[243],"toxicity":[245],"between":[246],"subtypes.":[249]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}